Author:
Deshpande L.M.,Jones R.N.
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference16 articles.
1. Tentative minimum inhibitory concentration and zone diameter breakpoints for moxifloxacin using BSAC criteria;Andrews;J Antimicrob Chemother,1999
2. Baron, E. J., & Murray, P. R. Bacteriology. In Murray, P. R., Barron, E. J., Pfaller, M. A., Tenover, F. C., & Yolken, R. H. (Eds) Manual of Clinical Microbiology, 6th ed. (pp. 246–662.) Washington, DC: ASM.
3. Treatment of community-acquired pneumonia. IDSA guidelines. Infectious Diseases Society of America;Bernstein;Chest,1999
4. Comparative activity of clinafloxacin and nine other comparator compounds tested against 2000 contemporary clinical isolates from patients in United States hospitals;Deshpande;Diagn Microbiol Infect Dis,1999
5. DiPersio J. R., Jones, R. N., Barrett, T., Doern, G. V., & Pfaller, M. A. (1998). Fluoroquinolone-resistant Moraxella catarrhalis in a patient with pneumonia: Report from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 32, 131–135.
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Preventing cardiac implantable electronic device infections;Heart Rhythm;2015-11
2. Activity In Vitro of the Quinolones;Quinolone Antimicrobial Agents;2014-04-08
3. Treatment of Community-Acquired Respiratory Tract Infections;Quinolone Antimicrobial Agents;2014-04-08
4. Gemifloxacin;Kucers' The Use of Antibiotics Sixth Edition;2010-10-29
5. Acute Exacerbations of Chronic Bronchitis;Wiley Handbook of Current and Emerging Drug Therapies;2006-09-15